Cor Vasa 2023, 65(3):508-513 | DOI: 10.33678/cor.2022.111

Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience

Mert Sarilar, Veysel Oktay, Gursu Demirci, Dogac Oksen, Vedat Sansoy
Department of Cardiology, Istanbul University - Cerrahpaşa Institute of Cardiology, Istanbul, Turkey

Background: Periprocedural myocardial injury and its clinical significance in stable patients are still under discussion. This subject has been assessed in many studies with different definitions, thresholds, and biomarkers for years. This study aimed to determine the clinical outcomes of periprocedural myocardial injury based on latest 4th UDMI guideline definitions.

Methods: 238 patients who underwent elective percutaneous coronary intervention at single center were retrospectively enrolled. Patients who developed periprocedural myocardial injury were compared with patients with normal troponin values after the procedure for clinical outcomes. Primary clinical endpoints were death, MI, stroke, refractory angina, target vessel revascularization and hospitalization due to acute coronary syndrome at one year.

Results: Periprocedural myocardial injury was observed in 67.2% (n = 160) of patients. Number of lesions and stents, total stent length, total stent diameter, post-dilatation, overlapping stents, bifurcation stenting and SYNTAX score were significantly higher in myocardial injury group. Clinical outcomes occurred in 16 patients, 11 of 16 had myocardial injury group, 5 of 16 had control group. No mortality was seen during the follow-up. Postprocedural troponin elevation was not associated with clinical outcomes (11 vs. 5, p = 0,56). Kaplan-Meier curve of clinical end points did not show any separation between the curves (Log rank test, 95% CI, p = 0,71).

Conclusion: Stent size and length, post-dilatation, overlapping stents and stenting of bifurcation lesions lead to increase in myocardial injury. Periprocedural myocardial injury in stable angina does not predict clinical outcomes at one year.

Keywords: Elective percutaneous coronary intervention, Periprocedural myocardial injury, Stable angina, Troponin

Received: September 14, 2022; Revised: September 14, 2022; Accepted: October 16, 2022; Published: June 20, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sarilar M, Oktay V, Demirci G, Oksen D, Sansoy V. Periprocedural myocardial injury after elective percutaneous coronary intervention in stable angina pectoris: a tertiary center experience. Cor Vasa. 2023;65(3):508-513. doi: 10.33678/cor.2022.111.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003. Go to original source...
    2. Christensen MK, Huang H, Torp-Pedersen C, et al. Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study. BMC Cardiovasc Disord 2016;16:16-140. Go to original source... Go to PubMed...
    3. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
    4. Thygesen K, Alpert JS, White HD, et al. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-2567. Go to original source...
    5. Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction. J Am Coll Cardiol 2018;72:2231-2264. Go to original source... Go to PubMed...
    6. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31:241-251. Go to original source... Go to PubMed...
    7. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000;85:1077-1082. Go to original source... Go to PubMed...
    8. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention related events different? Circulation 2002;105:554-556. Go to original source...
    9. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-1536. Go to original source...
    10. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-1887. Go to original source...
    11. Auguadro C, Scalise F, Manfredi M, et al. The prognostic role of troponin I elevation after elective percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 2015;16:149-155. Go to original source... Go to PubMed...
    12. Yang X, Tamez H, Lai C, et al. Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes. Catheter Cardiovasc Interv 2017;89:849-856. Go to original source... Go to PubMed...
    13. Zeitouni M, Silvain J, Guedeney P, et al.; ACTION Study Group. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J 2018;39:1100-1109. Go to original source...
    14. Garcia-Garcia HM, McFadden EP, von Birgelen C, et al. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv 2019;12:1954-1962. Go to original source... Go to PubMed...
    15. Zhou Y, Chen Z, Ma J, et al. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. J Cardiol 2020;76:309-316. Go to original source...
    16. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011;364:453-464. Go to original source... Go to PubMed...
    17. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005;26:2493-2519. Go to original source...
    18. Muschart X, Slimani A, Jamart J, et al. The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome. J Invasive Cardiol 2012;24:655-660. Go to PubMed...
    19. Bulluck H, Paradies V, Barbato E, et al. Prognostically relevant periprocedural myocardial injury and infarction associated withpercutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2021;42:2630-2642. Go to original source... Go to PubMed...
    20. Loeb HS, Liu JC. Frequency, risk factors, and effect on long-term survival of increased troponin I following uncomplicated elective percutaneous coronary intervention. Clin Cardiol 2010;33:E40-E44. Go to original source... Go to PubMed...
    21. Koskinas KC, Ndrepepa G, Raber L, et al. Prognostic impact of periprocedural myocardial infarction in patients undergoing elective percutaneous coronary interventions. Circ Cardiovasc Interv 2018;11:e006752. Go to original source... Go to PubMed...
    22. Abu Sharar H, Wohlleben D, Vafaie M, et al. Coronary angiography-related myocardial injury as detected by high-sensitivity cardiac troponin T assay. EuroIntervention 2016;12:337-344. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes